Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial

Yan-Lin Ren1, Zheng Jiang2,3, Jia-Yi Wang1

  • 1Department of Pathophysiology, West China College of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.

PubMed

Insights

New Parkinson's disease (PD) research reveals CHCHD2 mutations disrupt protein stability. This loss-of-function impairs mitochondrial function and neural cell viability, offering insights into neurodegenerative disease mechanisms.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Parkinson's disease (PD) is linked to CHCHD2 mutations causing protein instability.
  • The precise mechanisms and consequences of CHCHD2 loss-of-function in PD pathogenesis remain unclear.

Purpose of the Study:

  • To elucidate the functional impact of CHCHD2 loss-of-function on neural cells and mitochondrial integrity.
  • To investigate the role of the C1QBP/CHCHD2/CHCHD10 complex in regulating mitochondrial function and PD pathogenesis.

Main Methods:

  • In vitro and in vivo studies utilizing cell models and genetic manipulation (e.g., C1QBP silencing).
  • Analysis of protein stability, mitochondrial structure and function, autophagy, and mitophagy.
  • Identification of critical protein interaction motifs (aa125-133) within CHCHD2.

Main Results:

  • CHCHD2 deficiency, particularly due to C-terminal truncation, impairs neural cell viability and mitochondrial function.
  • The C1QBP/CHCHD2/CHCHD10 complex is crucial for maintaining mitochondrial integrity, with C1QBP regulating CHCHD2 and CHCHD10 stability.
  • CHCHD2 loss-of-function triggers compensatory upregulation of autophagy and mitophagy in response to cellular stress and mitochondrial damage.

Conclusions:

  • CHCHD2 plays a critical role in mitochondrial regulation through its interaction with CHCHD10 and C1QBP.
  • Dysfunction of the C1QBP/CHCHD2/CHCHD10 complex and subsequent CHCHD2 loss-of-function contribute to neurodegeneration in Parkinson's disease.
  • Targeting this complex may offer therapeutic strategies for neurodegenerative diseases associated with CHCHD2 dysfunction.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Cohesins02:20

Cohesins

Cohesin protein complexes are a molecular glue that holds two sister chromatids together. They play an important role both in mitosis and meiosis. In mitosis, all cohesin complexes present on the chromosomes are removed before the start of the anaphase stage.
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
4.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K